Infinata’s BioPharm Insight Partners with Global Medical Education to Expand Educational Services for Subscribers

Subscribers will receive free membership to the leading provider of online medical education and advice.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend

BioPharm Insight partners with Global Medical Education

This exciting partnership between BioPharm Insight and Global Medical Education will bring together two extremely powerful platforms and provide subscribers with the latest medical news, information and treatments.

New York, NY and Norwood, MA (PRWEB) June 27, 2013

Infinata’s BioPharm Insight announced today that it has partnered with Global Medical Education (GME) – an online resource that provides evidence-based medical education and online medical advice from the world’s leading experts to health care professionals globally.

Through this partnership, GME will provide BioPharm Insight subscribers with a complimentary membership to access GME’s online education platform. Members can take advantage of up-to-date, unbiased, evidence-based mental health advice and information on Central Nervous System topics. Additional membership benefits include:

  • Access to an online library of nearly 700 medical education videos that answer the most relevant, user-driven questions in psychiatry today; webcasts led by GME’s own world-renowned faculty.
  • GME’s monthly newsletter “GME Research Review,” with clinical commentary from leading
  • On-demand connections to and collaboration with renowned medical experts and thought-leaders from preeminent institutions around the world.
  • More face time with patients and colleagues through GME’s ease of use and concise delivery format.

“We are thrilled to be partnering with such a well-respected online educational resource for industry professionals in the mental health space,” said Ruth McHenry, Managing Director, Infinata. “We hope this will serve as a great opportunity for our valued subscribers to take advantage of the outstanding content GME provides.”

“This exciting partnership between BioPharm Insight and Global Medical Education will bring together two extremely powerful platforms and provide subscribers with the latest medical news, information and treatments,” said Dr. Prakash Masand, CEO and Founder of GME. “GME is truly honored to partner with BioPharm Insight, a worldwide leader in the biopharma community.”

To learn more about BioPharm Insight or to become a subscriber, visit http://www.biopharminsight.com or http://www.infinata.com/biopharma-solu tion/476-bpi-freetrial-gmed.html [sign up for complimentary trial access __title__ sign up for complimentary trial access].

About Global Medical Education

Global Medical Education is an online medical education resource that provides timely, unbiased, evidence-based medical education and online medical advice from the world’s leading experts to health care professionals around the world. GME provides answers to medical questions, from the common place to the most critical, in concise three to four minute medical education videos, available on-demand on all major digital devices. More information is available at http://www.gmeded.com.

About BioPharm Insight

BioPharm Insight is your definitive guide to the global biopharma community, combining an online business intelligence system of comprehensive market analytics, key industry contacts and an independent investigative journalist team. Based in New York, London, Washington DC, Hong Kong, Shanghai and Tokyo, the acclaimed journalist team has a proven track record of breaking global pharma business news ahead of the mainstream press. BioPharm Insight is published by Infinata, part of the Financial Times Group of companies and a division of Pearson plc. To learn more, visit http://www.biopharminsight.com.

About Infinata, Inc.

Infinata provides personalized technology solutions to turn information into insight. Services include a comprehensive BioPharm Solutions Suite, unique Wealth Prospecting tools and innovative Custom Data Services. Infinata is a part of Mergermarket, a Financial Times Group company and a division of Pearson plc. To learn more, visit http://www.infinata.com.


Contact

Follow us on: Contact's Twitter Contact's LinkedIn